Special Issue on "Hepatitis C in the Middle East and North Africa"
Middle East and North Africa (MENA) region has the highest prevalence and burden of hepatitis C worldwide. While there is great ambition toward elimination of hepatitis C worldwide, most of MENA countries are far from achieving the hepatitis C elimination goals. One of the obstacles is the lack of reliable scientific evidences on epidemiologic, virologic and clinical aspects of hepatitis C needed for policy making and advocacy of health interventions.
This Special Issue of Hepatitis Monthly invites all researchers in MENA region to submit their studies on hepatitis C to help the regional elimination of hepatitis C. The editorial board would offer 40% discount on all manuscripts accepted for this special issue. The submission for this special issue is open at https://hepatmon.brieflands.com/en/user/login
Special Issue Theme:
- Elimination of hepatitis C in MENA
Topics of particular interest:
- Epidemiology of hepatitis C in special populations (e.g. PWID, FSW, thalassemia, etc.)
- Molecular epidemiology of hepatitis C
- Efficacy and safety of hepatitis C direct-acting antivirals
- Hepatitis C resistance to direct-acting antivirals
- Hepatitis C model of care in special populations
- Micro-elimination and elimination of hepatitis C
- Management of hepatic and extra-hepatic complications of hepatitis C
- Burden of hepatitis C advanced liver diseases
Article types:
- Original articles
- Brief reports
- Review articles
- Letter to editors
Editor-in-chief:
- Seyed Moayed Alavian, Middle East Liver Diseases Center, Iran; Email: alavian@thc.ir
Guest associate editors:
- Wasim Jafri, Aga Khan University, Pakistan; Email: wasim.jafri@aku.edu
- Imam Waked, National Liver Institute, Menoufiya University, Egypt; Email: iwaked@liver-eg.org
- Heidar Sharafi, Middle East Liver Diseases Center, Iran; Email: h.sharafi@meldcenter.com
Submission deadline:
- 30 September 2022
Published Articles:
- This list will be updated regularly.